Literature DB >> 11165389

Fatal infection in patients treated for small cell lung cancer in the Institute of Tuberculosis and Chest Diseases in the years 1980-1994.

P Remiszewski1, J Słodkowska, E Wiatr, J Zych, P Radomski, E Rowińska-Zakrzewska.   

Abstract

The study was performed to explore the frequency of infections present at death and infection as the main cause of death (fatal infection - FI) in 845 consecutive patients (pts) treated for small cell lung cancer (SCLC) at the Institute of Tuberculosis and Chest Diseases in Warsaw, in the period 1980-1994. Diagnosis of infection was based on clinical signs and symptoms, the presence of new lesions on the chest X-ray, microbiological tests and/or autopsy examination. All cases of fungal infection, Pneumocystis carinii pneumonia (PCP) and tuberculosis were proved by autopsy and microscopic examination (including special staining). FI was diagnosed if no progression of cancer was noted and no other complications occurred. Infection was present at the time of death in 116 patients (13.7%) and FI was the cause of death in 39 of them (4.6%). Nine patients died from fungal infection, eight from bacterial infection, seven from PCP and two from tuberculosis. In 13 cases the aetiology of infection found at autopsy was not determined. All FI patients received chemotherapy and corticosteroids, 16 of them also had radiotherapy on the tumour and mediastinum. Thirty-two out of 35 patients had leucopenia. The risk of death from infection was greater in patients above 60 years of age. Patients in bad performance status died of infection significantly earlier than others (P<0.05).

Entities:  

Mesh:

Year:  2001        PMID: 11165389     DOI: 10.1016/s0169-5002(00)00185-9

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  5 in total

Review 1.  Lung cancer 7: management of lung cancer in elderly patients.

Authors:  R Booton; M Jones; N Thatcher
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

2.  A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients.

Authors:  Dan Qiao; Zhiyu Wang; Yaohong Lu; Xiaoting Wen; Hongtao Li; Hui Zhao
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 3.  Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19.

Authors:  Haoyue Guo; Xiaoxia Chen; Chunxia Su; Yu Liu; Hao Wang; Chenglong Sun; Peixin Chen; Minlin Jiang; Yi Xu; Shengyu Wu; Keyi Jia; Sha Zhao; Wei Li; Bin Chen; Lei Wang; Jia Yu; Anwen Xiong; Guanghui Gao; Fengying Wu; Jiayu Li; Lingyun Ye; Bing Bo; Shen Chen; Shengxiang Ren; Yayi He; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2020-04

4.  Unsuspected Pneumocystis pneumonia in an HIV-seronegative patient with untreated lung cancer: circa case report.

Authors:  Cai Chuang; Xie Zhanhong; Gu Yinyin; Zeng Qingsi; Zhong Shuqing; Zhong Nanshan
Journal:  J Med Case Rep       Date:  2007-10-28

5.  Retrospective analysis of the microbiological spectrum of pneumonia in Turkish patients with lung cancer.

Authors:  Nilüfer Avcı; Mustafa Hartavi; Turgut Kaçan; Murat Bayındır; Mustafa Avcı; Cüneyt Özakın; Aynur Engin; Adem Deliqönüll; Turkkan Evrensel; Halis Akalın
Journal:  Contemp Oncol (Pozn)       Date:  2016-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.